Amelia Kellar
@amelia_kellar
Followers
654
Following
2K
Media
36
Statuses
612
Director of Pediatric IUS, Co-Director Pediatric IBD @ComerChildrens @UChicago @bowelultrasound @iuscan|MD, MSc, FRCPC| (she/her) 🇨🇦
Chicago, IL
Joined January 2022
Excited to share our work spearheaded by @joelle_stpierre - Reliability and Validity of Mesenteric Fat Assessment by IUS in Pediatric CD Using the Chicago Mesenteric Fat Index https://t.co/CtKMnZv0Su Adult study coming soon! @DrMikeDolinger @mattsmyth_gi @KrugCleveland @IBDMD
academic.oup.com
AbstractBackground. Intestinal ultrasound (IUS) provides a noninvasive means of assessing Crohn’s disease (CD), including visualization of mesenteric fat (
1
7
31
Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn’s Disease: Opportunities and Challenges
academic.oup.com
Abstract. This narrative review summarizes the current knowledge on using intestinal ultrasonography (IUS) to evaluate disease activity in patients with Cr
0
3
9
When to Switch to Subcutaneous Infliximab? The RE-WATCH Multicenter Study
academic.oup.com
AbstractBackground. The infliximab (IFX) biosimilar, CT-P13, is available as an intravenous (IV) and subcutaneous (SC) formulation. Although current indica
0
6
14
Most patients have moderate to severe disease, & withholding effective therapy due to age or comorbidities only increases risk. The future? Decision support, EMR integration, and predictive tools powered by genetics + OMICs #AIBD2025 #IBD #PersonalizedMedicine #PrecisionTherapy
0
6
19
Kicking off Day 2 of #AIBD2025 with an update of the newest #IBD guidelines by @tinahamd and Dr. David Rubin. Helping providers navigate the growing number of medications used in IBD treatment. 💊📚 #Healthcare #MedEd #Gastroenterology
0
23
60
@SimonHongMD incorporating telehealth into IBD care works - triage is key: ‼️High-alert triggers for alarm symptoms 🏨Clear escalation protocols 💊Remote med + symptom monitoring Still bring patients in for post-op checks, perianal complaints, and 1st-time med teaching #AIBD2025
1
4
9
Efficacy of IL-12/23 and IL-23 Antagonists for Moderate... : Official journal of the American College of Gastroenterology | ACG
journals.lww.com
An abstract is unavailable.
0
2
4
Shameless plug of this abstract featuring @Evinature_ CurQD in #PediatricIBD showing improvement in symptoms, calprotectin and even #IUS presented at #CCCongress2024! #AIBD2025
2
4
10
COMBINE trial: ➡️ADA+MTX=2x reduction in tx failure in pediatric CD vs ADA monotherapy, but 🚫IFX+MTX VEDOKIDS ➡️42% UC, 32% CD in SFCR +EN-free remission W14 UPA peds retrospective ➡️52% SFCR W8 ➡️56% CD, 90% UC SFCR at 6mth
1
5
15
New ESPGHAN/ECCO ASUC Consensus take-aways: ➡️VTE prophylaxis in all hospitalized pts ➡️IFX 10mg/kg-use TDM to guide dosing ➡️PJP prophylaxis in appropriate scenario: triple immunosuppression, double immunosuppression (1 CNI), steroid + low lymphocytes or JAKi #aibd2025
0
6
31
🔔 @ericbenchimol kicking off the #PedsIBD update session with a blockbuster new ESPGHAN/ECCO guideline for UC (#ASUC)! Key highlights: • Higher infliximab dosing with smarter TDM • How to sequence therapies in ASUC • Use of dual advanced therapies 💥 • VTE prophylaxis •
0
2
4
JAKne: 💊 seen with JAKi, especially upadacitinib 🧴Treatment includes: Topical retinoid, benzoyl peroxide, clindamycin, isoretinoin (details in linked review). #AIBD2025 @acharrow
https://t.co/ZrKn8KxnGR
onlinelibrary.wiley.com
Click on the article title to read more.
0
11
25
AIH & IBD 🧪Initial screening: ANA, ASMA and IgG. If neg but suspicion is high: LKM and SLA. 🔬Bx required for dx #aibd2025 @sidbarritt4
0
1
2
UC & PSC=higher risk of dysplasia ➡️Higher risk of chronic pouchitis post-IPAA ➡️More data needed as to whether IPAA vs ileostomy impacts graft complications post liver tx ➡️Multi-D approach is essential to prevent pre-malignant transformation #AIBD2025
0
5
15
At #AIBD2025, we reviewed the European ECCO-ESPGHAN pediatric CD guideline, which recommends exclusive enteral nutrition (EEN) as a first-line option for inducing remission in low-risk luminal Crohn’s. 🥤 EEN offers strong mucosal outcomes but remains socially challenging for
1
11
19
IPAA afferent limb strictures may masquerade as pouchitis: today’s surgery session at #AIBD2025 hammered home the need to think structural when symptoms don’t fit the script. Short strictures = endoscopic options; long strictures = operative solutions. #MedTwitter #IBD #GI
1
5
7
Algorithm approach to pain in IBD highlighted this afternoon. Very informative way to frame the issue based on presence (or not) of inflammation and next steps, published by #LaurieKeeferPhD @HorstIBDDoc
0
3
7
Pediatric IBD year-in-review: Global data (I contributed from Sinai!) across UC and CD show UPA induces fast, robust remission in treatment-refractory kids, with biomarkers improving by Week 8. Acne the most common side effect. Evidence is growing—and so are our options.
1
7
15
📏 @ericbenchimol presenting a new pediatric IUS insight: In children with IBD who are in sustained deep remission, previously inflamed bowel wall thickness measures <2.5 mm—notably lower than the 3 mm cutoff used in adults—and this held true regardless of age, sex, or bowel
pubmed.ncbi.nlm.nih.gov
Previously inflamed BWT for children with IBD in sustained deep remission was less than 2.5 mm, which is less than 3 mm in adults, and unaffected by age, sex, and bowel segment in this population....
1
6
9